Dna X (SONM) Other Accumulated Expenses (2018 - 2023)

Dna X's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $391000.0 for Q3 2023.

• Quarterly Other Accumulated Expenses fell 62.69% year-over-year to $391000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $391000.0 (down 62.69% YoY) and the FY2022 annual result came in at $171000.0, down 49.85% from the prior year.
• Other Accumulated Expenses was $391000.0 for Q3 2023 at Dna X, up from $364000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $1.2 million in Q2 2022 and bottomed at $16000.0 in Q1 2023.
• A 5-year average of $510600.0 and a median of $377500.0 in 2023 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2020 — Other Accumulated Expenses declined 0.3% — and 2023, when it plunged 94.63%.
• Dna X's Other Accumulated Expenses stood at $657000.0 in 2019, then retreated by 0.3% to $655000.0 in 2020, then slumped by 47.94% to $341000.0 in 2021, then slumped by 49.85% to $171000.0 in 2022, then soared by 128.65% to $391000.0 in 2023.
• Business Quant data shows SONM's Other Accumulated Expenses at $391000.0 in Q3 2023, $364000.0 in Q2 2023, and $16000.0 in Q1 2023.